Ohr Pharmaceutical, Inc. ( OHRP ) was a big mover last session, as the company saw its shares rise by almost 17% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now almost 51% in the past one-month time frame.
This drugs company has seen no estimate revision over the past 30 days while its Zacks Consensus Estimate has moved down over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.
Ohr Pharmaceutical has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Some stocks in the same industry looking equally good include POZEN Inc. ( POZN ), Aerie Pharmaceuticals, Inc. ( AERI ) and Ariad Pharmaceuticals Inc. ( ARIA ). While POZEN holds a Zacks Rank #1 (Strong Buy), Aerie Pharmaceuticals and Ariad Pharmaceuticals carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days .Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free reportOHR PHARMACEUT (OHRP): Get Free ReportPOZEN INC (POZN): Get Free ReportAERIE PHARMACT (AERI): Get Free ReportARIAD PHARMA (ARIA): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment Research